Non-Hodgkin's Lymphoma [clinicaltrials_resource:96b810e493464a1f41cdaeedec1037a7]
Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00022893]Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement [clinicaltrials:NCT00022906]Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP [clinicaltrials:NCT00022932]Expanded Access Study of Iodine-131 Anti-B1 Antibody [clinicaltrials:NCT00022958]A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma [clinicaltrials:NCT00038545]Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma [clinicaltrials:NCT00041730]A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas. [clinicaltrials:NCT00042666]Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma. [clinicaltrials:NCT00043459]Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade) [clinicaltrials:NCT00044902]Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma [clinicaltrials:NCT00048555]Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL) [clinicaltrials:NCT00051025]Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00054808]Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma [clinicaltrials:NCT00057343]Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients [clinicaltrials:NCT00057447]Treatment of Non-Hodgkin's Lymphoma With 90Y-hLL2 IgG [clinicaltrials:NCT00061425]Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab [clinicaltrials:NCT00062894]Pegfilgrastim PBPC Mobilization Study [clinicaltrials:NCT00066092]Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00069758]SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL) [clinicaltrials:NCT00076349]Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL [clinicaltrials:NCT00077961]A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00078598]Xcellerated T CellsTM for Non-Hodgkin’s Lymphoma (NHL) Patients [clinicaltrials:NCT00081783]Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma [clinicaltrials:NCT00086034]Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma [clinicaltrials:NCT00090038]Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00090727]Use of Topotecan in Patients With Refractory Acute Leukemia [clinicaltrials:NCT00100477]Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia [clinicaltrials:NCT00109356]Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma [clinicaltrials:NCT00115193]A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00117455]Treatment for Subjects With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00117897]Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients [clinicaltrials:NCT00120198]Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma [clinicaltrials:NCT00129090]Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies [clinicaltrials:NCT00131014]Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809) [clinicaltrials:NCT00133302]Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus [clinicaltrials:NCT00133367]clinicaltrials:NCT00136474Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab [clinicaltrials:NCT00139841]Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation [clinicaltrials:NCT00144677]Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation [clinicaltrials:NCT00144703]Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma [clinicaltrials:NCT00147953]
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Non-Hodgkin's Lymphoma [clinicaltrials_resource:96b810e493464a1f41cdaeedec1037a7]
Bio2RDF identifier
96b810e493464a1f41cdaeedec1037a7
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:96b810e493464a1f41cdaeedec1037a7
identifier
clinicaltrials_resource:96b810e493464a1f41cdaeedec1037a7
title
Non-Hodgkin's Lymphoma
@en
label
Non-Hodgkin's Lymphoma [clinicaltrials_resource:96b810e493464a1f41cdaeedec1037a7]
@en